Ainos, Inc. (AIMD)

Market Cap	13.34M +20.2%
Revenue (ttm)	113,037 +178.2%
Net Income	-14.96M
EPS	-4.06
Shares Out	6.98M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	247,215
Open	1.990
Previous Close	1.950
Day's Range	1.720 - 2.070
52-Week Range	1.610 - 4.500
Beta	2.38
Analysts	n/a
Price Target	n/a
Earnings Date	Mar 6, 2026

About AIMD

Ainos, Inc., a dual-platform AI and biotech company, focusing SmellTech, AI diagnostics, and immune therapeutics. Its AI Nose platform uses a smell language model to digitize scent into Smell IDs and turning invisible chemical signals into machine-readable data. The company is also giving AI for robotics, smart factories, senior care, and women’s health. In addition, it develops VELDONA, a low-dose oral interferon targeting rare, autoimmune, and infectious diseases, plus applications in animal health. The company was formerly known as Amarillo ...

• Industry: Scientific & Technical Instruments
• Sector: Technology
• Founded: 1984
• Employees: 44
• Stock Exchange: NASDAQ
• Ticker Symbol: AIMD
• Website: https://www.ainos.com

Financial Performance

In 2024, Ainos's revenue was $20,729, a decrease of -83.02% compared to the previous year's $122,112. Losses were -$14.86 million, 7.93% more than in 2023.